COVID-19 has spread to most regions and territories around the world. As of May 2, 2023, the number of confirmed cases had reached roughly 687 million.

COVID-19 in the Americas The Americas is one of the regions most impacted by COVID-19. The number of coronavirus cases and deaths are particularly high in the United States and Brazil. The pandemic has had a devastating impact on Latin America, and several nations have recorded a resurgence in cases, highlighting the complexity of easing restrictions while the virus is still a threat. However, mass vaccination programs have been launched in countries including Argentina, Chile, and Panama.

The role of face masks in the prevention of COVID-19 There has been much discussion about the effectiveness of face masks in slowing the spread of the COVID-19 disease. Many governments around the world made it mandatory to wear a form of face mask, particularly in shops and on public transport. Masks alone will not halt the spread of the disease, and they should be used alongside other measures such as social distancing.

These tables compile data provided to DDS by California's 21 regional centers. Updates received from each regional center every business day include information for individuals known to them to have tested positive for COVID-19. Data is provisional and may change as regional centers provide updates. Details regarding gender, age group, and self-reported ethnicity are retrieved from separate databases of information for all regional center consumers.

Context

Data is extremely valuable; it can be considered a key to discovering trends and predicting the future. Studying already existent data can help provide a certain level of preparedness for any situation that may come. The aim is to obtain data of COVID-19 Statistics in India and compile it into a dataset, so that it can be used to visualize and analyze trends and patterns so as to prepare for the possibilities that may come. Presence of missing values allows its use for the study of imputation algorithms. It can also be used for building time-series models.

Acknowledgements

https://api.apify.com/v2/datasets/58a4VXwBBF0HtxuQa/items?format=json&clean=1 https://www.mohfw.gov.in/

Deaths involving coronavirus disease 2019 (COVID-19) reported to NCHS by time-period, HHS region, race and Hispanic origin, and age groups (<65, 65-74. 75-84, 85+, and 65+). United States death counts include the 50 states, plus the District of Columbia and New York City. The ten (10) United States Department of Health and Human Services (HHS) regions include the following jurisdictions. Region 1: Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Vermont; Region 2: New Jersey, New York, New York City; Region 3: Delaware, District of Columbia, Maryland, Pennsylvania, Virginia, West Virginia; Region 4: Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina, South Carolina, Tennessee; Region 5: Illinois, Indiana, Michigan, Minnesota, Ohio, Wisconsin; Region 6: Arkansas, Louisiana, New Mexico, Oklahoma, Texas; Region 7: Iowa, Kansas, Missouri, Nebraska; Region 8: Colorado, Montana, North Dakota, South Dakota, Utah, Wyoming; Region 9: Arizona, California, Hawaii, Nevada; Region 10: Alaska, Idaho, Oregon, Washington.

NOTE: This dataset has been retired and marked as historical-only. The recommended dataset to use in its place is https://data.cityofchicago.org/Health-Human-Services/COVID-19-Vaccination-Coverage-Region-HCEZ-/5sc6-ey97. COVID-19 vaccinations administered to Chicago residents by Healthy Chicago Equity Zones (HCEZ) based on the reported address, race-ethnicity, and age group of the person vaccinated, as provided by the medical provider in the Illinois Comprehensive Automated Immunization Registry Exchange (I-CARE). Healthy Chicago Equity Zones is an initiative of the Chicago Department of Public Health to organize and support hyperlocal, community-led efforts that promote health and racial equity. Chicago is divided into six HCEZs. Combinations of Chicago’s 77 community areas make up each HCEZ, based on geography. For more information about HCEZs including which community areas are in each zone see: https://data.cityofchicago.org/Health-Human-Services/Healthy-Chicago-Equity-Zones/nk2j-663f Vaccination Status Definitions: ·People with at least one vaccine dose: Number of people who have received at least one dose of any COVID-19 vaccine, including the single-dose Johnson & Johnson COVID-19 vaccine. ·People with a completed vaccine series: Number of people who have completed a primary COVID-19 vaccine series. Requirements vary depending on age and type of primary vaccine series received. ·People with a bivalent dose: Number of people who received a bivalent (updated) dose of vaccine. Updated, bivalent doses became available in Fall 2022 and were created with the original strain of COVID-19 and newer Omicron variant strains. Weekly cumulative totals by vaccination status are shown for each combination of race-ethnicity and age group within an HCEZ. Note that each HCEZ has a row where HCEZ is “Citywide” and each HCEZ has a row where age is "All" so care should be taken when summing rows. Vaccinations are counted based on the date on which they were administered. Weekly cumulative totals are reported from the week ending Saturday, December 19, 2020 onward (after December 15, when vaccines were first administered in Chicago) through the Saturday prior to the dataset being updated. Population counts are from the U.S. Census Bureau American Community Survey (ACS) 2017-2021 5-year estimates. Coverage percentages are calculated based on the cumulative number of people in each population subgroup (age group by race-ethnicity within an HCEZ) who have each vaccination status as of the date, divided by the estimated number of people in that subgroup. Actual counts may exceed population estimates and lead to >100% coverage, especially in small race-ethnicity subgroups of each age group within an HCEZ. All coverage percentages are capped at 99%. All data are provisional and subject to change. Information is updated as additional details are received and it is, in fact, very common for recent dates to be incomplete and to be updated as time goes on. At any given time, this dataset reflects data currently known to CDPH. Numbers in this dataset may differ from other public sources due to when data are reported and how City of Chicago boundaries are defined. CDPH uses the most complete data available to estimate COVID-19 vaccination coverage among Chicagoans, but there are several limitations that impact its estimates. Data reported in I-CARE only includes doses administered in Illinois and some doses administered outside of Illinois reported historically by Illinois providers. Doses administered by the federal Bureau of Prisons and Department of Defense are also not currently reported in I-CARE. The Veterans Health Administration began reporting doses in I-CARE beginning September 2022. Due to people receiving vaccinations that are not recorded in I-CARE that can be linked to their record, such as someone receiving a vaccine dose in another state, the number of people with a completed series or a booster dose is underesti

From August 2024, statistical tables of cases by region, age group, and gender (disease name: severe cases of COVID-19, date type: onset date, case type: confirmed cases, source of infection: whether imported from abroad). This dataset is updated once daily according to a fixed schedule by the system, presenting statistical information up to the previous day.

The number of daily new COVID-19 cases started to decline across Europe from the start of April 2020. However, infections continued to increase in the Americas, and the World Health Organization (WHO) identified the region as the new epicenter of the pandemic toward the end of May 2020.

Soaring demand for critical health care supplies Health systems around the world have been overwhelmed because of the coronavirus. Hospitals have reached capacity and health workers have been redirected to care for critical COVID-19 patients. Demand for test kits, respirators, and personal protective equipment (PPE) has led to global shortages of life-saving supplies. The WHO had shipped 131 million units of medical PPE – face masks, goggles, gloves, and gowns – to nearly 150 countries as of August 10, 2020.

Russia claim vaccine prestige Since the start of the pandemic, there has been an urgent need to accelerate the development of COVID-19 treatments. As of August 13, 2020, there are 29 candidate vaccines under clinical evaluation around the world, according to the WHO. One of those vaccines is being developed by the Gamaleya Research Institute of Epidemiology and Microbiology in Moscow. Russian President Vladimir Putin granted the vaccine regulatory approval in mid-August, and it is expected to enter civilian circulation in January 2021.

About Dataset: WHO COVID-19 Global Data

This dataset provides comprehensive information on the global COVID-19 pandemic as reported to the World Health Organization (WHO). The dataset is available in comma-separated values (CSV) format and includes the following fields:

Daily cases and deaths by date reported to WHO: WHO-COVID-19-global-data.csv

• Date_reported (Date): The date of reporting to WHO.
• Country_code (String): The ISO Alpha-2 country code.
• Country (String): The name of the country, territory, or area.
• WHO_region (String): The WHO regional office to which the country belongs. WHO Member States are grouped into six WHO regions, including AFRO (Regional Office for Africa), AMRO (Regional Office for the Americas), SEARO (Regional Office for South-East Asia), EURO (Regional Office for Europe), EMRO (Regional Office for the Eastern Mediterranean), and WPRO (Regional Office for the Western Pacific).
• New_cases (Integer): The number of new confirmed cases reported on a given day. This is calculated by subtracting the previous cumulative case count from the current cumulative case count.
• Cumulative_cases (Integer): The total cumulative confirmed cases reported to WHO up to the specified date.
• New_deaths (Integer): The number of new confirmed deaths reported on a given day. Similar to new cases, this is calculated by subtracting the previous cumulative death count from the current cumulative death count.- Cumulative_deaths (Integer): The total cumulative confirmed deaths reported to WHO up to the specified date.

In addition to the COVID-19 case and death data, this dataset also includes valuable information related to COVID-19 vaccinations. The vaccination data consists of the following fields:

Vaccination Data Fields: vaccination-data.csv

• COUNTRY (String): Country, territory, or area.
• ISO3 (String): ISO Alpha-3 country code.
• WHO_REGION (String): The WHO regional office to which the country belongs.
• DATA_SOURCE (String): Indicates the data source, which can be either "REPORTING" (Data reported by Member States or sourced from official reports) or "OWID" (Data sourced from Our World in Data COVID-19 Vaccinations).
• DATE_UPDATED (Date): Date of the last update.
• TOTAL_VACCINATIONS (Integer): Cumulative total vaccine doses administered.
• PERSONS_VACCINATED_1PLUS_DOSE (Decimal): Cumulative number of persons vaccinated with at least one dose.
• TOTAL_VACCINATIONS_PER100 (Integer): Cumulative total vaccine doses administered per 100 population.
• PERSONS_VACCINATED_1PLUS_DOSE_PER100 (Decimal): Cumulative persons vaccinated with at least one dose per 100 population.
• PERSONS_LAST_DOSE (Integer): Cumulative number of persons vaccinated with a complete primary series.
• PERSONS_LAST_DOSE_PER100 (Decimal): Cumulative number of persons vaccinated with a complete primary series per 100 population.
• VACCINES_USED (String): Combined short name of the vaccine in the format "Company - Product name."
• FIRST_VACCINE_DATE (Date): Date of the first vaccinations, equivalent to the start/launch date of the first vaccine administered in a country.
• NUMBER_VACCINES_TYPES_USED (Integer): Number of vaccine types used per country, territory, or area.
• PERSONS_BOOSTER_ADD_DOSE (Integer): Cumulative number of persons vaccinated with at least one booster or additional dose.
• PERSONS_BOOSTER_ADD_DOSE_PER100 (Decimal): Cumulative number of persons vaccinated with at least one booster or additional dose per 100 population.

In addition to the vaccination data, a separate dataset containing vaccination metadata is available, including information about vaccine names, product names, company names, authorization dates, start and end dates of vaccine rollout, and more.

Vaccination metadata Fields: vaccination-metadata.csv

• ISO3 (String): ISO Alpha-3 country code
• VACCINE_NAME (String): Combined short name of vaccine: "Company - Product name" (see below)
• PRODUCT_NAME (String): Name or label of vaccine product, or type of vaccine (if unnamed).
• COMPANY_NAME (String): Marketing authorization holder of vaccine product.
• FIRST_VACCINE_DATE (Date): Date of first vaccinations. Equivalent to start/launch date of the first vaccine administered in a country.
• AUTHORIZATION_DATE (Date): Date vaccine product was authorized for use in the country, territory, area.
• START_DATE (Date): Start/launch date of vaccination with vaccine type (excludes vaccinations during clinical trials).
• END_DATE (Date): End date of vaccine rollout
• COMMENT (String): Comments related to vaccine rollout
• DATA_SOURCE (String): Indicates data source - REPORTING: Data reported by Member States, or sourced from official re...

From August 2024, statistics on the deaths of confirmed cases of severe COVID-19 complications will be provided, classified by confirmed disease name, onset time, region, age group, and gender. This dataset is updated daily according to a fixed system schedule, presenting statistics as of the previous day.

COVID-19 Global Case and Death Data

Global COVID-19 Cases and Deaths Over Time

By Coronavirus (COVID-19) Data Hub [source]

About this dataset

The COVID-19 Global Time Series Case and Death Data is a comprehensive collection of global COVID-19 case and death information recorded over time. This dataset includes data from various sources such as JHU CSSE COVID-19 Data and The New York Times.

The dataset consists of several columns providing detailed information on different aspects of the COVID-19 situation. The COUNTRY_SHORT_NAME column represents the short name of the country where the data is recorded, while the Data_Source column indicates the source from which the data was obtained.

Other important columns include Cases, which denotes the number of COVID-19 cases reported, and Difference, which indicates the difference in case numbers compared to the previous day. Additionally, there are columns such as CONTINENT_NAME, DATA_SOURCE_NAME, COUNTRY_ALPHA_3_CODE, COUNTRY_ALPHA_2_CODE that provide additional details about countries and continents.

Furthermore, this dataset also includes information on deaths related to COVID-19. The column PEOPLE_DEATH_NEW_COUNT shows the number of new deaths reported on a specific date.

To provide more context to the data, certain columns offer demographic details about locations. For instance, Population_Count provides population counts for different areas. Moreover,**FIPS** code is available for provincial/state regions for identification purposes.

It is important to note that this dataset covers both confirmed cases (Case_Type: confirmed) as well as probable cases (Case_Type: probable). These classifications help differentiate between various types of COVID-19 infections.

Overall, this dataset offers a comprehensive picture of global COVID-19 situations by providing accurate and up-to-date information on cases, deaths, demographic details like population count or FIPS code), source references (such as JHU CSSE or NY Times), geographical information (country names coded with ALPHA codes) , etcetera making it useful for researchers studying patterns and trends associated with this pandemic

How to use the dataset

• Understanding the Dataset Structure:

  • The dataset is available in two files: COVID-19 Activity.csv and COVID-19 Cases.csv.
  • Both files contain different columns that provide information about the COVID-19 cases and deaths.
  • Some important columns to look out for are: a. PEOPLE_POSITIVE_CASES_COUNT: The total number of confirmed positive COVID-19 cases. b. COUNTY_NAME: The name of the county where the data is recorded. c. PROVINCE_STATE_NAME: The name of the province or state where the data is recorded. d. REPORT_DATE: The date when the data was reported. e. CONTINENT_NAME: The name of the continent where the data is recorded. f. DATA_SOURCE_NAME: The name of the data source. g. PEOPLE_DEATH_NEW_COUNT: The number of new deaths reported on a specific date. h.COUNTRY_ALPHA_3_CODE :The three-letter alpha code represents country f.Lat,Long :latitude and longitude coordinates represent location i.Country_Region or COUNTRY_SHORT_NAME:The country or region where cases were reported.

• Choosing Relevant Columns: It's important to determine which columns are relevant to your analysis or research question before proceeding with further analysis.

• Exploring Data Patterns: Use various statistical techniques like summarizing statistics, creating visualizations (e.g., bar charts, line graphs), etc., to explore patterns in different variables over time or across regions/countries.

• Filtering Data: You can filter your dataset based on specific criteria using column(s) such as COUNTRY_SHORT_NAME, CONTINENT_NAME, or PROVINCE_STATE_NAME to focus on specific countries, continents, or regions of interest.

• Combining Data: You can combine data from different sources (e.g., COVID-19 cases and deaths) to perform advanced analysis or create insightful visualizations.

• Analyzing Trends: Use the dataset to analyze and identify trends in COVID-19 cases and deaths over time. You can examine factors such as population count, testing count, hospitalization count, etc., to gain deeper insights into the impact of the virus.

• Comparing Countries/Regions: Compare COVID-19

Research Ideas

• Trend Analysis: This dataset can be used to analyze and track the trends of COVID-19 cases and deaths over time. It provides comprehensive global data, allowing researchers and po...

Deaths involving coronavirus disease 2019 (COVID-19) by month of death, region, age, place of death, and race and Hispanic origin.

Provisional count of deaths involving coronavirus disease 2019 (COVID-19) in the United States by week of death and by hospital referral region (HRR). HRR is determined by county of occurrence. Weekly weighted counts of deaths from all causes and due to COVID-19 are provided by HRR overall and for decedents 65 years and older. The weighted counts by HRRs are based on published methods for aggregating county-level data to HRRs. More detail about aggregating to HRRs from counties can be found in the following: https://github.com/Dartmouth-DAC/covid-19-hrr-mapping https://dartmouthatlas.org/covid-19/hrr-mapping/

Interact with Georgia COVID-19 statistics by County, Region and MSA published by the Atlanta Regional Commission, continuously updated.Data source: 1Point3Acres.com, Georgia Department of Public HealthLearn More About Global Spread Trend:COVID-19 tracker , Edward Parker & Quentin Leclerc at London School of Hygiene & Tropical MedicineLearn More About Exponential Growth and Doubling Time:Exponential growth , WikipediaWhy "Exponential Growth" Is So Scary For The COVID-19 Coronavirus, Ethan Siegel at Forbes.comCoronavirus 10-day forecast, Ben Phillip at the University of MelbourneLearn More About Longer Term Spread Prediction and Healthcare Capacity:Modeling COVID-19 Spread vs Healthcare Capacity , Alison Hill at the Harvard UniversityCOVID-19 Projections, Institute for Health Metrics and Evaluation at the University of Washington

Yahoo Knowledge Graph COVID-19 Datasets

Background

The Yahoo Knowledge Graph team at Verizon Media is responsible for providing critical COVID-19 data that feeds into Yahoo properties like Yahoo News, Yahoo Finance, and Yahoo Weather. The COVID-19 datasets include country, state, and county level information updated on a rolling basis, with updates occuring approximately hourly.

The COVID-19 datasets are constructed entirely from primary (government and public agency) sources with a clear attribution of the primary sources used for each geographical region. While other aggregations of COVID-19 data are already available, we believe ours to be the only open source COVID-19 dataset that is constructed entirely from primary sources with clear attribution back to those sources. Our hope is that additional transparency will enable more accurate analysis, aiding researchers who seek to understand and prevent further spread of the disease.

Released together with the COVID-19 dataset are two other open source projects:

• An API powered by Elide, which provides JSON-API and GraphQL interfaces to the COVID-19 public data
• A dashboard to explore the data

Datasets

The data is logically organized by region and time. Time is further organized into a snapshot of the latest updates received for all regions and the updates reported by regions for a given date. As the COVID-19 pandemic develops and local governments and agencies improve their ability to collect and present their data to the public, the schema will evolve. Please check back as sources frequently evolve.

We welcome data feeds or links to web pages that you would like us to crawl, extract, and merge into the overall stats. Feel free to submit an issue.

region-metadata

Provides general information about the regions covered in the dataset, such as geographical location and links to other public data sources.

by-region-[DATE]

Provides detailed case counts of COVID-19 in each region on [DATE] in local time for that region. Each entry (row) in the daily file represents a single region.

Please be aware that different sources release data at different and often unpredictable frequencies. The by-region-[DATE] numbers will be updated as sources release data for the given date for their region. In some cases, data for a given region is not released until many days after that calendar date has elapsed everywhere in the world. As a result, the same by-region-[DATE] file may show different aggregate statistics for the same date depending on when the by-region-[DATE] is accessed. Generally speaking, by-region-[DATE] data more than one week old is stable.

NSSP Emergency Department (ED) Visit Trajectories by State and Sub-State Regions- COVID-19, Flu, RSV, Combined. This dataset provides the percentage of emergency department patient visits for the specified pathogen of all ED patient visits for the specified geographic part of the country that were observed for the given week from data submitted to the National Syndromic Surveillance Program (NSSP). In addition, the trend over time is characterized as increasing, decreasing or no change, with exceptions for when there are no data available, the data are too sparse, or there are not enough data to compute a trend. These data are to provide awareness of how the weekly trend is changing for the given geographic region.  Note that the reported sub-state trends are from Health Service Areas (HSA) and the data reported from the health care facilities located within the given HSA. Health Service Areas are regions of one or more counties that align to patterns of care seeking. The HSA level data are reported for each county in the HSA. More information on HSAs is available here. For the emergency department time series, trajectory classifications reported on for sub-state (HSA) emergency department time series, trajectory classifications are based on approximations of the first derivative (slope) of trends that are smoothed using generalized additive models (GAMs). To determine time intervals in which the slope is sufficiently changing (i.e., rate of change distinguishable from 0), 95% confidence intervals for the slope approximations are calculated and assessed. Weeks with a 95% confidence interval not containing 0 are classified as increasing if the slope estimate is positive and decreasing if the slope estimate is negative. Weeks with a 95% confidence interval containing 0 are classified as stable. In the scenario that an HSA's time series is determined to be too sparse (i.e., many weeks with percentages of 0%), a model is not fit, and the HSA is classified as “sparse”. For additional information, please see: Companion Guide: NSSP Emergency Department Data on Respiratory Illness Updated once per week on Fridays.

In the second quarter of 2020, Asia-Pacific, with **** percent, had the largest share of the worldwide COVID-19 diagnostic testing market. Europe had the second-largest market share at **** percent, followed by North America at ** percent.

As of December 8, 2022, the number of confirmed COVID-19 cases in Finland reached a total of 1,417,909. The majority of the cases were discovered in the region of Helsinki and Uusimaa, where the health care district has confirmed in total 545,988 cases. The first case of the coronavirus (COVID-19) in Finland was confirmed on January 29, 2020.

The worldwide number of confirmed cases of coronavirus was almost 646 million on November 28, 2022. For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.

This file contains COVID-19 death counts and rates by jurisdiction of residence (U.S., HHS Region) and demographic characteristics (sex, age, race and Hispanic origin, and age/race and Hispanic origin). United States death counts and rates include the 50 states, plus the District of Columbia. Deaths with confirmed or presumed COVID-19, coded to ICD–10 code U07.1. Number of deaths reported in this file are the total number of COVID-19 deaths received and coded as of the date of analysis and may not represent all deaths that occurred in that period. Counts of deaths occurring before or after the reporting period are not included in the file. Data during recent periods are incomplete because of the lag in time between when the death occurred and when the death certificate is completed, submitted to NCHS and processed for reporting purposes. This delay can range from 1 week to 8 weeks or more, depending on the jurisdiction and cause of death. Death counts should not be compared across jurisdictions. Data timeliness varies by state. Some states report deaths on a daily basis, while other states report deaths weekly or monthly. The ten (10) United States Department of Health and Human Services (HHS) regions include the following jurisdictions. Region 1: Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Vermont; Region 2: New Jersey, New York; Region 3: Delaware, District of Columbia, Maryland, Pennsylvania, Virginia, West Virginia; Region 4: Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina, South Carolina, Tennessee; Region 5: Illinois, Indiana, Michigan, Minnesota, Ohio, Wisconsin; Region 6: Arkansas, Louisiana, New Mexico, Oklahoma, Texas; Region 7: Iowa, Kansas, Missouri, Nebraska; Region 8: Colorado, Montana, North Dakota, South Dakota, Utah, Wyoming; Region 9: Arizona, California, Hawaii, Nevada; Region 10: Alaska, Idaho, Oregon, Washington. Rates were calculated using the population estimates for 2021, which are estimated as of July 1, 2021 based on the Blended Base produced by the US Census Bureau in lieu of the April 1, 2020 decennial population count. The Blended Base consists of the blend of Vintage 2020 postcensal population estimates, 2020 Demographic Analysis Estimates, and 2020 Census PL 94-171 Redistricting File (see https://www2.census.gov/programs-surveys/popest/technical-documentation/methodology/2020-2021/methods-statement-v2021.pdf). Rate are based on deaths occurring in the specified week and are age-adjusted to the 2000 standard population using the direct method (see https://www.cdc.gov/nchs/data/nvsr/nvsr70/nvsr70-08-508.pdf). These rates differ from annual age-adjusted rates, typically presented in NCHS publications based on a full year of data and annualized weekly age-adjusted rates which have been adjusted to allow comparison with annual rates. Annualization rates presents deaths per year per 100,000 population that would be expected in a year if the observed period specific (weekly) rate prevailed for a full year. Sub-national death counts between 1-9 are suppressed in accordance with NCHS data confidentiality standards. Rates based on death counts less than 20 are suppressed in accordance with NCHS standards of reliability as specified in NCHS Data Presentation Standards for Proportions (available from: https://www.cdc.gov/nchs/data/series/sr_02/sr02_175.pdf.).

Effective September 27, 2023, this dataset will no longer be updated. Similar data are accessible from wonder.cdc.gov. Deaths involving COVID-19 reported to NCHS by time-period, HHS region, race and Hispanic origin, and age group. United States death counts include the 50 states, plus the District of Columbia and New York City. The ten (10) United States Department of Health and Human Services (HHS) regions include the following jurisdictions. Region 1: Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Vermont; Region 2: New Jersey, New York, New York City, Puerto Rico; Region 3: Delaware, District of Columbia, Maryland, Pennsylvania, Virginia, West Virginia; Region 4: Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina, South Carolina, Tennessee; Region 5: Illinois, Indiana, Michigan, Minnesota, Ohio, Wisconsin; Region 6: Arkansas, Louisiana, New Mexico, Oklahoma, Texas; Region 7: Iowa, Kansas, Missouri, Nebraska; Region 8: Colorado, Montana, North Dakota, South Dakota, Utah, Wyoming; Region 9: Arizona, California, Hawaii, Nevada; Region 10: Alaska, Idaho, Oregon, Washington.

The most affected city by the coronavirus pandemic (COVID-19) in Romania was Bucharest, with 633.9 thousand people having tested positive as of November 21, 2022. By contrast, Covasna had fewer than 22.3 thousand people who tested positive. For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.